While most studies have used glucose-insulin-potassium (GIK) as insulin treatment, in this study we used hyperinsulinemic euglycemic clamping for this purpose because maintenance of euglycemia eliminates the possible effects of hypo- and hyperglycemia on myocardial perfusion and function itself [32]. This evidence concerns the gene INS and Hyperglycemia.